| Literature DB >> 27824877 |
Yang Yang1,2,3,4,5, Yu-Zhi Shi1,3,4,5, Ning Zhang1,2,3,4,5, Shuo Wang1,3,4,5, Gabor S Ungvari6,7, Chee H Ng8, Yi-Long Wang1,3,4,5, Xing-Quan Zhao1,3,4,5, Yong-Jun Wang1,3,4,5, Chun-Xue Wang1,2,3,4,5, Yu-Tao Xiang9.
Abstract
Few studies on long-term functional outcome have been conducted in post-stroke patients in China. The objective of this study was to conduct a nationwide survey in China to investigate the 5-year prevalence of post-stroke disability and its correlation factors. A total of 893 patients with ischemic stroke were included. Demographic, clinical and neuro-imaging information were collected with standardized instruments that assessed stroke severity, depression, cognitive impairment, stroke recurrence and physical disability. Disability was assessed with the modified Ranking Score (mRS), of which a cutoff score ≥2 indicates disability. Statistical analysis included chi-square tests, two independent samples t-tests, Mann-Whitney U test and multiple logistic regression analysis. The frequency of disability in this study population was 45%. Multivariate analyses revealed that older age, lower education level, previous history of stroke, stroke severity at admission, depression, cognitive impairment at 3 months, and stroke recurrence within 5 years follow up were all significantly associated with post-stroke disability. The disability rate in 5-year post-stroke was high in Chinese patients. Treatment of depression, secondary prevention of stroke and rehabilitation may benefit disabled patients with stroke in China.Entities:
Mesh:
Year: 2016 PMID: 27824877 PMCID: PMC5100878 DOI: 10.1371/journal.pone.0165341
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flow diagram of the recruitment.
Comparison between stroke patients with and without disability at 5-year follow up with respect to demographic and clinical characteristics.
| Male | 614 | 68.8 | 352 | 71.7 | 262 | 65.2 | 4.3 | 1 | |
| Married/ cohabited | 842 | 94.3 | 469 | 95.5 | 373 | 92.8 | 3.0 | 1 | 0.08 |
| High school or above | 367 | 41.1 | 219 | 44.6 | 148 | 36.8 | 5.5 | 1 | |
| Diabetes | 217 | 24.3 | 106 | 21.6 | 111 | 27.6 | 4.3 | 1 | |
| Hyperlipidemia | 249 | 28.3 | 130 | 27.0 | 119 | 29.9 | 0.9 | 1 | 0.33 |
| Hypertension | 620 | 69.4 | 328 | 66.8 | 292 | 72.6 | 3.5 | 1 | 0.06 |
| Cardiac disease | 189 | 21.3 | 89 | 18.2 | 100 | 25.0 | 6.0 | 1 | |
| Current smoking | 333 | 37.4 | 205 | 41.9 | 128 | 31.9 | 9.4 | 1 | |
| Moderate/Heavy-drinking | 138 | 15.5 | 94 | 19.1 | 44 | 10.9 | 11.3 | 1 | |
| Stroke History | 197 | 22.1 | 70 | 14.3 | 127 | 31.6 | 38.6 | 1 | |
| Stroke Family History | 179 | 20.1 | 104 | 21.2 | 75 | 18.8 | 0.8 | 1 | 0.36 |
| Large-Artery etiology | 570 | 63.8 | 308 | 62.7 | 262 | 65.2 | 0.5 | 1 | 0.44 |
| Cardio-embolism etiology | 24 | 2.7 | 9 | 1.8 | 15 | 3.7 | 3.0 | 1 | 0.08 |
| Small-vessels etiology | 216 | 24.2 | 118 | 24.0 | 98 | 24.4 | 0.01 | 1 | 0.90 |
| Other determined or undetermined etiology | 41 | 4.6 | 27 | 5.5 | 14 | 3.5 | 2.0 | 1 | 0.15 |
| Left lesions | 328 | 36.7 | 180 | 36.7 | 148 | 36.8 | 0.002 | 1 | 0.96 |
| Right lesions | 335 | 37.5 | 192 | 39.1 | 143 | 35.6 | 1.1 | 1 | 0.27 |
| Frontal lobe | 114 | 12.8 | 63 | 12.8 | 51 | 12.7 | 0.004 | 1 | 0.94 |
| Temporal lobe | 77 | 8.6 | 42 | 8.6 | 35 | 8.7 | 0.007 | 1 | 0.93 |
| Parietal lobe | 87 | 9.7 | 51 | 10.4 | 36 | 9.0 | 0.5 | 1 | 0.47 |
| Occipital lobe | 63 | 7.1 | 34 | 6.9 | 29 | 7.2 | 0.02 | 1 | 0.86 |
| Basal ganglia | 433 | 48.5 | 240 | 48.9 | 193 | 48.0 | 0.06 | 1 | 0.79 |
| Thalamus | 84 | 9.4 | 49 | 10.0 | 35 | 8.7 | 0.4 | 1 | 0.51 |
| Brainstem | 186 | 20.8 | 102 | 20.8 | 84 | 20.9 | 0.002 | 1 | 0.96 |
| Cerebellum | 68 | 7.6 | 36 | 7.3 | 32 | 8.0 | 0.1 | 1 | 0.72 |
| Cerebral Lesions | 237 | 26.5 | 133 | 27.1 | 104 | 25.9 | 0.1 | 1 | 0.68 |
| Sub-cortical Lesions | 495 | 55.4 | 274 | 55.8 | 221 | 55.0 | 0.06 | 1 | 0.80 |
| Infra-tentorial Lesions | 232 | 26.0 | 128 | 26.1 | 104 | 25.9 | 0.005 | 1 | 0.94 |
| Cognitive Impairment at 3 months | 129 | 14.4 | 41 | 8.4 | 88 | 21.9 | 32.7 | 1 | |
| Depression at 3 months | 198 | 22.2 | 90 | 18.3 | 108 | 26.9 | 9.3 | 1 | |
| Stroke recurrence within 5-years | 211 | 23.6 | 65 | 13.2 | 146 | 36.3 | 65.2 | 1 | |
| Age (yrs) | 60.6 | 10.7 | 57.6 | 10.2 | 64.2 | 10.2 | -9.5 | 891 | |
| NIHSS score at admission | 4.4 | 3.6 | 3.9 | 3.2 | 5.0 | 3.9 | -4.0 | —a | |
| HRSD total at 3 months | 4.8 | 4.8 | 4.3 | 4.5 | 5.3 | 5.0 | -3.2 | —a | |
| MMSE total at 3 months | 27.2 | 3.6 | 28.1 | 2.4 | 26.2 | 4.4 | -7.3 | —a | |
Bold values are p<0.05; a = Mann-Whitney U test; HRSD = Hamilton Rating Scale for Depression-17; MMSE = Mini Mental State Examination; NIHSS = National Institutes of Health Stroke Scale; Toast = Trial of Org 10172 in Acute Stroke Treatment
Independent correlates of disability at 5 years in stroke patients (multiple logistic regression analysis with the group without disability as reference group).
| Stroke patients | |||
|---|---|---|---|
| Variables | p | OR | 95% CI |
| Age | 1.06 | 1.04,1.08 | |
| Male | 0.20 | 0.7 | 0.4,1.1 |
| High school or above | 0.6 | 0.4,0.9 | |
| Diabetes | 0.75 | 1.06 | 0.7,1.6 |
| Cardiac Disease | 0.69 | 1.09 | 0.7,1.6 |
| Current smoking | 0.09 | 1.4 | 0.9,2.2 |
| Moderate/Heavy Drinking | 0.65 | 1.1 | 0.6,1.9 |
| Stroke History | 2.6 | 1.7,4.1 | |
| NIHSS score at admission | 1.1 | 1.05,1.1 | |
| Depression at 3 months | 1.8 | 1.1,2.9 | |
| Cognitive impairment at 3 months | 2.7 | 1.6,4.7 | |
| Stroke Recurrence within 5 years | 4.1 | 2.7,6.3 | |
Bold values are p<0.05
* adjusting for study site; NIHSS = National Institutes of Health Stroke Scale